Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) announced on Wednesday the initiation of polymer process development and analytical characterization activities by Nanosoft Polymers in support of ONC010, the company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase inhibitor. The work includes polymer synthesis optimization, characterization methodology development, molecular weight assessment, purification strategy refinement and manufacturing scalability assessments as part of Onco-Innovations' chemistry, manufacturing and controls strategy.
The company said the activities are intended to establish a scalable, reproducible and analytically characterized polymer platform to support future formulation, manufacturing, regulatory and clinical development. Onco-Innovations noted that Nanosoft's expertise in polymer science and nanoparticle drug delivery is expected to strengthen the technical foundation of the ONC010 platform while supporting future GMP manufacturing readiness.
This development marks a key step for Onco-Innovations as it moves ONC010 closer to clinical trials. The company holds an exclusive worldwide license to patented technology targeting solid tumors, and ONC010 represents its most advanced candidate. The collaboration with Nanosoft aims to ensure that the drug can be produced consistently and at scale, which is critical for regulatory approval and eventual commercialization.
For investors, this announcement signals progress in de-risking the manufacturing process, a common hurdle for nanoparticle-based therapies. Successful scale-up could position Onco-Innovations to advance ONC010 into clinical studies, potentially offering a new treatment option for solid tumor cancers. The full press release is available at https://nnw.fm/BeSoS.
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. The company's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. For the latest news and updates on ONNVF, visit the company's newsroom at https://nnw.fm/ONNVF.
